Mahamaya Lifesciences Limited (BOM:544611)
India · Delayed Price · Currency is INR 186.00
-2.00 (-1.06%)
At close: Aug 14, 2026
Mahamaya Lifesciences Revenue
In the fiscal year ending March 31, 2026, Mahamaya Lifesciences had annual revenue of 3.29B INR with 24.46% growth. Mahamaya Lifesciences had revenue of 1.66B in the half year ending March 31, 2026.
Revenue
3.29B
Revenue Growth
+24.46%
P/S Ratio
1.32
Revenue / Employee
42.16M
Employees
78
Market Cap
4.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.29B | 646.37M | 24.46% |
| Mar 31, 2025 | 2.64B | 1.03B | 63.54% |
| Mar 31, 2024 | 1.62B | 244.50M | 17.83% |
| Mar 31, 2023 | 1.37B | 472.02M | 52.49% |
| Mar 31, 2022 | 899.19M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Southern Petrochemical Industries Corporation | 29.56B |
| Best Agrolife | 12.72B |
| Excel Industries | 10.73B |
| Khaitan Chemicals and Fertilizers | 9.88B |
| Rama Phosphates | 9.28B |
| Advance Agrolife | 8.00B |
| Aries Agro | 7.66B |
| Shivalik Rasayan | 3.68B |